Antiviral Effects of TXA as a Preventative Treatment Following COVID-19 Exposure (TXACOVIDPREV)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04550338 |
Recruitment Status :
Withdrawn
(With vaccination efforts ongoing, a feasibility survey indicated there would be inadequate recruitment)
First Posted : September 16, 2020
Last Update Posted : April 23, 2021
|
Sponsor:
University of Alabama at Birmingham
Information provided by (Responsible Party):
Timothy Ness, MD, University of Alabama at Birmingham
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : | Withdrawn |
---|---|
Estimated Primary Completion Date : | December 31, 2022 |
Estimated Study Completion Date : | March 31, 2023 |